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Abstract 
 
Background: Vernonia amygdalina, commonly called bitter-leaf, is widely consumed in many parts of Africa, and Nigeria, in 
particular. The leaf extract has been reported to have antimicrobial, anti-plasmodial, anti-helminthic, as well as prebiotic properties, 
but its immuno-modulatory effects have not been well-studied, neither have the prebiotics been identified. This study evaluated the 
immuno-modulatory properties of the aqueous leaf extract and identified the prebiotic components.  
Methods: The immuno-modulatory potential was evaluated by monitoring the effects of oral administration of the extract on 
immunological, haematological and lipid profiles of Rattus norvegicus, while the prebiotic components were identified by thin layer 
chromatography (TLC), following liquid-liquid fractionation of the extract.  
Results: Consumption of the extract caused significant increases in CD4+-, white blood cell-, total lymphocyte- and high density 
lipid (HDL) counts; decreases in low density lipid (LDL) and triglycerides and no significant effect on haemoglobin (Hb) and 
packed cell volume (PCV) in the blood of test animals. The water-soluble fraction of the extract contained most of the phyto-
constituents of the extract and Thin Layer Chromatographic analysis of the fraction revealed the presence of fructo-oligosaccharide 
and galacto-oligosaccharide prebiotics.  
Conclusion: The results from this study have shown that the aqueous leaf extract of V. amygdalina has positive immune-modulatory 
and haematologic effects and contains some important prebiotic compounds.  
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Introduction 
 
Vernonia amygdalina, a member of the Asteraceae family, is a widely used local vegetable in Nigeria, Uganda and other 
African countries. It grows in a range of ecological zones in Africa and the Arabian Peninsula. The leaf is commonly called “bitter 
leaf” in English. It is a shrub of 2-5 m tall with petiolate leaves of about 6.0 mm wide. It is up to 20 cm long and its bark is rough 
(Ojiako and Nwanjo, 2006; Ijeh and Ejike, 2011). The bitter taste of the leaf has been attributed to the presence of anti-nutritive 
principles like saponins, alkaloids, tannins and glycosides (Ijeh and Ejike, 2011). There have been several reports on its 
antimicrobial, antiplasmodial, antitumor, antioxidant and antihelminthic properties (Farombi and Owoeye, 2011; Udochukwu et al., 
2015). Aqueous leaf extracts of V. amygdalina have also been previously reported to have prebiotic effects (Ezeonu et al., 2012).  
Prebiotics are non-digestible food ingredients that beneficially affect the host by selectively stimulating the growth and/or 
activity of one or a limited number of beneficial bacteria in the colon and thus improve host health (Gibson and Roberfroid, 1995). 
The roles of prebiotics in modulation of bowel function, inhibition of pathogenic bacteria and reduction of colon cancer have been 
widely studied and reported (Gibson and Roberfroid, 1995; Hamilton-Miller, 2004; Lomax and Calder, 2009; Chakraborti, 2011; 
Licht et al., 2011). Prebiotics have also been reported to have positive effects on haematological and biochemical parameters, as well 
as lipid metabolism in both human and animal models (Lomax and Calder, 2009; Ooi and Liong, 2010; Jackson and Lovegrove, 
2012; Scavuzzi et al, 2014).  
The most widely studied prebiotics are inulin and non-digestible oligosaccharides such as oligofructose (Watzl et al., 2005; 
Leenen and Dieleman, 2007; Guarner, 2007; Lomax and Calder, 2009; Patel and Goyal, 2012). However, some studies suggest that 
there may be other candidate-prebiotics such as xylitol, sorbitol, mannitol and lactulose (Chakraborti, 2011). This study aimed to 
evaluate the immuno-modulatory properties of V. amygdalina extracts and identify the prebiotic components in the extract. 
 
 
Methodology 
Collection of plant materials and preparation of aqueous plant leaf extracts  
 
The leaves of V. amygdalina used for this study were obtained from a local market in Nsukka and authenticated by a 
botanist from the Department of Botany, University of Nigeria, Nsukka (Voucher number: U.N.H. {University of Nigeria 
Herbarium}/001). 
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Extraction procedure 
 
The leaves were washed in clean water and dried. The dried leaves were pulverized into a homogenous powder using 
mortar and pestle. One hundred grams (100 g) of the powder was soaked in 1 L of water for 24 h with intermittent stirring. The 
aqueous extract was filtered through a 2 mm mesh filter and the filtrate was stored at 4˚C in clean sterile bottles. 
 
 
Liquid-liquid fractionation of crude extract 
 
Fractionation of the V. amygdalina extract was carried out by sequential extraction with chloroform, ethyl-acetate and N-
butanol, according to the methods of Ajali (2004). Briefly, the crude extract obtained as described above was concentrated to dryness 
by air-drying. The concentrated extract was re-extracted with chloroform and filtered through a Whatman no. 1 filter paper. The 
filtrate (chloroform-soluble fraction) was evaporated to obtain the extract. The residue was air-dried and extracted with methanol for 
6 hr, washed five times with methanol and then filtered. The methanol extract was dried and the residue washed three times with 
ethyl-acetate. The ethyl-acetate fraction was separated and the residue re-extracted with N-butanol. All solvents were from JHD, 
China.  
 
Phytochemical analysis of crude extract 
 
The crude extract was analyzed phytochemically in the Department of Pharmacognosy, University of Nigeria, Nsukka, 
using standard methods outlined by Harborne (1984) and later modified by Trease and Evans (1996). The extracts were tested for 
carbohydrates, reducing sugars, steroids and terpenoids, phenols and tannins, alkaloids, saponins, flavonoids, oils and glycosides. 
 
Thin Layer Chromatography (TLC)  
 
The various fractions were analyzed using Thin Layer Chromatography method described by Harborne (1984) and later 
modified by Trease and Evans (1996). TLC plates of 5 cm height and of various convenient widths were cut from large sheets. The 
plates were handled carefully in order not to disturb the coating of adsorbent or get them dirty. A distance of 0.5 cm was measured 
from the bottom of the plate. Then, using a pencil, a line was drawn across the plate at the 0.5 cm mark, to mark the origin. Under 
the line, the names of the samples to be spotted were labelled lightly. Samples were spotted using a 10 µl microcapillary. The spots 
were spaced out appropriately to prevent mixing. The prepared TLC plate was then placed in the developing beaker and covered 
with a watch glass. The set-up was left undisturbed to develop until the solvent was about half a centimeter below the top of the 
plate. The plate was then removed from the beaker and the solvent front immediately marked with a pencil. The plate was allowed to 
air-dry. Coloured spots were circled lightly with a pencil and the plates were placed on a prepared iodine chamber to enhance 
visibility of the bands. Sample sugars (standards) were run alongside the extracts. The Retardation factor (Rf) values of the standards 
and extracts were measured and compared to determine the probable sugars present in the extracts. 
 
Collection of animals 
 
Experimental animals (Rattus norvegicus) of either sex, weighing between 150-200 g, were purchased from a commercial 
supplier. The rats were housed in well ventilated cages in the animal house of the Faculty of Biological sciences, University of 
Nigeria, Nsukka. The animals were allowed free access to feed (growers guinea feed) and clean water according to the guidelines of 
the National Institute of Health (NIH) publications for laboratory animal care and use (NIH, 1985). The animals were acclimatized to 
the housing and feeding conditions for a period of ten days prior to testing. 
 
Administration of aqueous extract to animals 
 
The animals were carefully grouped according to similar body weights. There were a total of six groups with six animals 
per group. One group was set as a control while the other five groups were administered different concentrations of the aqueous leaf 
extracts. The control groups were administered distilled water while other groups were administered oral doses of 50, 100, 200, 400 
and 800 mg/kg of the aqueous extracts reconstituted in distilled water, respectively, twice daily for three weeks. The animals were 
monitored for another seven days before they were sacrificed.    
 
Haematological assays 
 
Blood samples were obtained by the orbital bleeding method. A microhaematocrit capillary tube was inserted at the medial 
canthus to gain access to the orbital venous plexus of the rats. Twenty microlitre (20 µl) aliquots of blood were used to determine 
Haemoglobin level, Packed Cell Volume, White Blood Cell, CD4+ cells population and Lymphocyte counts, respectively, according 
to the methods described by Cheesbrough (2006). 
 
Biochemical assays 
 
The animals were allowed to fast for about 16 h. Then, blood samples were drawn as described above. The tubes 
containing the blood samples were kept at 4oC for the sera to separate. Aliquots (200 µl) were used for the determination of serum 
Total Cholesterol (TC), Triglyceride (TG), High Density Lipoprotein Cholesterol (HDL-C) and Low Density Lipoprotein 
Cholesterol (LDL-C), respectively, according to the methods outlined by Cheesbrough (2006).  
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Statistical Analysis 
  
The results obtained in this research work were expressed as mean ± standard deviation. The differences between mean 
values were assessed for significance by Analysis of variance (ANOVA) at P < 0.05 level of significance. 
 
 
Results and Discussion 
 
Four fractions were recovered from the leaf extract with chloroform, ethyl-acetate and N-butanol (2 fractions, a lower and 
upper). The residue, which did not dissolve in any solvent but water, was called the water residue and taken as a fifth fraction. The 
fractions were designated E1 to E5. From 35 g of crude extract, the yields of the five fractions were as follows: chloroform fraction 
(E1), 0.1 g (0.29%); water residue (E2), 18 g (51.43%); ethyl acetate fraction (E3), 0.5 g (1.43%); N-butanol lower faction (E4), 13.8 
g (39.43%) and N-butanol upper fraction (E5), 1.0 g (2.86%). The total weight recovered was 33.4 g (95.4%) and the weight loss 
was calculated to be 1.6 g (4.6%). Phytochemical analysis revealed that the crude extract contained carbohydrates, reducing sugars, 
glycosides, saponin, steroid, tannin and oil. These components were distributed among the different fractions as shown in Table 1. 
The water residue (E2) was the most abundant fraction and also contained most of the phyto-constituents, including carbohydrates, 
reducing sugars, steroids, saponins and tannins. A previous study had shown this fraction to be the most active, in terms of 
stimulation of growth of beneficial bacteria (Ukwah and Ezeonu, 2009). 
 
 
Table 1: Phytochemical composition of the crude Vernonia amygdalina aqueous leaf extract and five fractions (E1 to E5) produced 
by liquid-liquid fractionation of the crude extract 
 
   Fractions    
Constituents Crude extract E1 E2 E3 E4 E5 
Carbohydrates +++ + ++ + + + 
Reducing sugars ++ - ++ NT - - 
Glycosides ++ - ++ NT - - 
Saponins +++ - +++ - - - 
Flavonoids - - - - - - 
Resin - - - - - - 
Steroids ++ - + NT + NT 
Terpenoids - - - - - - 
Alkaloids - - - - - - 
Tannins ++ - + - + + 
Oil ++ + - + ++ + 
 
Key: - = absent; + = trace quantity; ++ = moderate quantity; +++ = high quantity; NT = not tested  
 
 
The presence of saponin is of particular interest in this study. Saponins are complex glycosides made up of sugar (glycone) 
and non-sugar (aglycone) groups. The glycone can consist of a single group of sugars (monosaccharides) or several groups of sugars 
(oligosaccharides) (LASCU, 2008). The foaming characteristic usually observed with saponins is caused by the combination of the 
non-polar aglycone and the water soluble side chain (glycone) and on contact with water, the sugar group dissolves releasing the 
non-sugar group (Ajali, 2004; Shi et al, 2004; LASCU, 2008). Saponins have been reported to have biological activities including 
anti-inflammatory, anticancer, immune stimulating, antimicrobial and anti-plasmodial properties (Ajali, 2004; Ray, 2007). In 
addition, saponins are believed to be non-systemic and able to escape digestion in the upper gut to arrive in the colon (Ajali, 2004). 
This latter property is an important property of all prebiotics. 
The effect of the extract on CD4+ (cluster of differentiation 4) cell counts, haematological and lipid profiles was evaluated 
using the water residue. In the control (untreated) animals, there were no significant differences in counts throughout the 
experimental period. However, in the test groups, there was a general increase in CD4+ counts with administration of the extract. The 
effect was dose-dependent, with counts increasing with increase in dose of extract up to 200 mg/kg body weight, after which the 
CD4+ counts decreased again. The CD4+ count at 800 mg/kg was lower than the count recorded at 50 mg/kg but higher than control.  
The differences were significant (p<0.05). Similarly, consumption of the extract caused increases in total white blood cell 
(WBC) and total lymphocyte counts (Table 2).  
cells that organize the immune system’s response to infections. They are the core of adaptive immunity, the system that 
tailors the body’s immune response to specific pathogens. They are called helper cells because one of their main roles is to send 
signals to other types of immune cells, including CD8+ killer cells, which destroy the infectious particle. If CD4+ cells become 
depleted, for example in untreated HIV infection, or following immune suppression prior to a transplant, the body is left vulnerable 
to a wide range of infections that it would otherwise have been able to fight (Ansari-Lari et al., 1996). The increase in CD4+ cell 
counts observed in test animals administered with oral doses of the V. amygdalina extract, in this study, strongly suggests a positive 
immuno-modulatory effect of the extract. The extract did not produce any significant effects on haemoglobin and PCV in this study.  
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Table 2: Effects of Different Oral Doses of V. amygdalina Aqueous Leaf Extract on Some Blood Parameters 
 
Parameters 
 
Baseline Values 
(Values at zero 
time) 
 
Treatment 
Groups/ Dose  
 
Values after 21 days 
Treatment 
 
 
7 Days after 
Completion of 
Treatment 
     
CD4+ cell counts 52.1 + 0.07 A (Control) 52.3±0.05  55.0±0.06  
(cells/ml)  B (50 mg/kg) 356.0±0.12*  227.0±0.11*  
  C (100 mg/kg) 509.3±0.05*  301.0±0.06*  
  D (200 mg/kg) 1147.7±0.11*  701.0±0.12*  
  E (400 mg/kg) 486.0±0.00*  109.0±0.05*  
  F (800mg/kg) 239.7±0.00*  113.0±0.11*  
     
Haemoglobin 13.6 + 0.02 A (Control) 14.0±0.12  15.3±0.00  
(g/dL)  B (50 mg/kg) 13.3±0.05  13.9±0.06 
  C (100 mg/kg) 13.7±0.11  14.3±0.12  
  D (200 mg/kg) 14.0±0.11  14.7±0.00  
  E (400 mg/kg) 14.0±0.12  15.5±0.11  
  F (800mg/kg) 14.7±0.00  17.0±0.12  
     
Packed Cell Volume 39.8 + 0.06 A (Control) 41.0±0.00  34.0±0.06  
(%)  B (50 mg/kg) 40.3±0.05  37.0±0.06  
  C (100 mg/kg) 39.7±0.05  30.0±0.00  
  D (200 mg/kg) 40.3±0.05  39.0±0.00  
  E (400 mg/kg) 41.7±0.00  39.0±0.00  
  F (800mg/kg) 43.0±0.05  40.0±0.06  
 
Total WBC Counts 6.9 + 0. 04 A (Control) 6.7±0.00  6.8±0.00  
(x109/L)  B (50 mg/kg) 14.7±0.00*  8.3±0.06*  
  C (100 mg/kg) 16.1±0.12*  9.6±0.12*  
  D (200 mg/kg) 15.0±0.00*  10.2±0.00*  
  E (400 mg/kg) 21.0±0.00*  17.8±0.05*  
  F (800mg/kg) 17.5±0.06*  9.0±0.00*  
     
Lymphocytes 6.8 + 4.56 A (Control) 7.08±4.16 5.92±4.08 
(x109/L)  B (50 mg/kg) 73.00±8.32 48.00±0.00* 
  C (100 mg/kg) 71.33±5.03 60.00±1.02* 
  D (200 mg/kg) 64.00±12.16 70.00±0.03* 
  E (400 mg/kg) 75.33±11.54 62.00±0.00* 
  F (800mg/kg) 69.33±8.08 54.00±0.06* 
*: significant (p<0.05)  
 
Evaluation of the lipidaemic effect of the V. amygdalina extract showed a general increase in serum cholesterol in the 
blood of the test animals. However, separate measurements of high density lipoprotein cholesterol (HDL-C) and low density 
lipoprotein cholesterol (LDL-C) showed that while there were significant increases in HDL-C levels of the test animals, there were 
decreases in LDL-C. Similarly, there were significant decreases in triglycerides. The effects were also dose-dependent (Table 3). 
Lipid profile is useful in assessing the risk of cardiovascular disease and is usually altered in the serum in various disease states in 
humans (Betteridge, 1994). LDL-C, sometimes called “bad” cholesterol transports cholesterol mainly to the arterial wall, thus 
leading to formation of arteriosleretic plaque, which is a major cause of cardiovascular disease (Latunde-Dada, 1990). In contrast, 
HDL-C, called “good” cholesterol binds to arterial cholesterol and transports it to the liver for metabolism. Therefore, any 
substances that can increase the HDL-C level, but decrease the LDL-C level will play an important role in the reduction of 
cardiovascular diseases (Yokozawa et al., 2006). The results in this study are therefore significant.  
The best known prebiotics are Inulin, fructooligosacharides and galactooligosaccharides, even though the existence of 
other candidate prebiotics has been suggested (Sharma et al, 2012). In this study, attempts to identify prebiotic components of the V. 
amygdalina extract by TLC, showed the presence of compounds with Rf values of 0.20, 0.28, 0.16 and 0.23, similar to those of D-
Fructose, D-Xylose, D-Glucose , D-Arabinose, D-Mannose and D-Galactose (Table 4). These results indicate that the extract 
contains fructo-oligosaccharides and galacto-oligosaccharides, among others, which are known prebiotics. 
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Table 3: Effects of Oral Administration of V. amygdalina Aqueous Leaf Extract on Lipid  Profile 
 
Parameters 
 
Baseline Values 
(Values at zero 
time; mg/dL) 
 
Treatment 
Groups/ Dose  
 
Values after 21 
days Treatment 
(mg/dL) 
 
 
7 Days after Completion 
of Treatment (mg/dL) 
     
Total Cholesterol 38.0 + 0.15 A (Control) 60.3±0.00 65.4±0.00 
  B (50 mg/kg) 54.7±0.06* 49.0±0.00* 
  C (100 mg/kg) 62.7±0.00*  54.0±0.00*  
  D (200 mg/kg) 59.7±0.00*  67.0±0.05*  
  E (400 mg/kg) 52.0±0.05*  63.0±0.00*  
  F (800mg/kg) 65.7±0.00*  50.0±0.12* 
     
High Density Lipids  15.1 + 0.06 A (Control) 16.0±0.00  19.7±0.04 
(HDL)  B (50 mg/kg) 33.6±0.09*  28.0±0.06*  
  C (100 mg/kg) 37.6±0.03*  31.1±0.12* 
  D (200 mg/kg) 40.3±0.06*  35.3±0.11*  
  E (400 mg/kg) 42.3±0.01* 39.4±0.06*  
  F (800mg/kg) 27.0±0.09*  23.7±0.00* 
     
Low Density Lipids  48.2 + 4.24 A (Control) 52.3±0.05  52.9±0.06 
(LDL)  B (50 mg/kg) 50.0±0.52*  54.0±0.00*  
  C (100 mg/kg) 31.3±0.03*  35.0±0.05* 
  D (200 mg/kg) 32.1±0.00* 37.0±0.06* 
  E (400 mg/kg) 31.3±0.05*  36.0±0.00* 
  F (800mg/kg) 29.6±0.05*  32.0±0.07*  
     
Triglycerides 43.5 + 3.56 A (Control) 53.6±0.13  57.0±0.00  
  B (50 mg/kg) 40.6±0.10*  43.0±0.06* 
  C (100 mg/kg) 37.3±0.03*  39.0±0.00* 
  D (200 mg/kg) 30.6±1.24*  36.0±0.00*  
  E (400 mg/kg) 27.6±0.15*  29.0±0.12* 
  F (800mg/kg) 19.3±0.05*  23.0±0.11*  
*: significant (p<0.05) 
 
 
Cholesterol is synthesized from long chain fatty acids, which are attached to the glycerol side chain of triglycerides. Thus, 
increase in triglyceride level often increases synthesis of cholesterol from the liver, and therefore increases the risk of cardiovascular 
disease (Richards et al., 1989). Reduction in level of triglycerides of test animals by consumption of V. amygdalina extracts, in this 
study, agrees with reports of other investigators that V. amygdalina has a serum- lipid-modulation property and can reduce 
arthersclerosis in animal models (Ijeh and Ejike, 2011; Abdulmalik et al., 2016). They are also in agreement with studies which have 
reported that prebiotics can cause favourable redistributions of lipids among the various lipoproteins (Busserolles et al., 2003; 
Lomax and Calder, 2009; Ooi and Liong, 2010; Jackson and Lovegrove, 2012; Sharma et al., 2012; Salahuddin et al., 2013; 
Scavuzzi et al, 2014). 
 
The best results were observed in this study using the dose of 200 mg/kg. This is in agreement with the report of 
Abdulmalik et al. (2016). 
 
White blood cells are the cells that are involved in defending the body against both infectious disease and foreign invaders. 
The increased WBC count in treated groups suggests improved immune-response. Increase in total WBC count could occur by 
different mechanisms, including increased production of white blood cells, absence of re-distribution of white blood cells from 
peripheral blood into the tissues or reduced destruction of white blood cells (Bruce et al., 2002; Handin et al., 2003; El-Demerdash, 
2004). In this study, the exact mechanism responsible for the increased WBC counts could not be confirmed. However, an increase 
in number of lymphocytes was observed and T-cell activation is usually an indication of a boost in the immune system. It is usually 
measured as a way to assess the health of patients with HIV/AIDS and in other disorders (Kwong et al., 1998; Zamani et al., 2010). 
CD4+ cells, a subset of T-cells, are of particular importance in assessing the immune status of a patient. CD4+ cells are white blood.  
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Table 4: Thin Layer Chromatographic Identification of Oligosaccharides in Aqueous Extract of V. amygdalina Leaves 
 
Standards/ 
Fractions 
Samples Tested Rf Values (cm) Probable Oligosaccharides 
Identified 
Standards    
 D-Fructose 0.23 - 
 D-Mannose 0.20 - 
 D-Xylose 0.28 - 
 D-Galactose 0.16 - 
Extract Fractions    
 Chloroform 0.20 Mannosyl-oligosaccharide 
 Water Residue   
  0.15 Galacto-oligosaccharide 
  0.18 Galacto-oligosaccharide 
 N-butanol (Upper Layer)   
  0.28 Xylo-oligosaccharide 
  0.23 Fructo-oligosaccharide 
 N-butanol (Lower Layer) 0.21 Arabino-oligosaccharide 
 
Conclusion 
 
The results from this study have shown that the aqueous leaf extract of V. amygdalina has positive immune-modulatory 
and haematologic effects and contains some important prebiotic compounds.  
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